𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nanohybrids Composed of Quantum Dots and Cytochrome P450 as Photocatalysts

✍ Scribed by Binil Itty Ipe; Christof M. Niemeyer

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
175 KB
Volume
45
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cover Picture: Nanohybrids Composed of Q
Cover Picture: Nanohybrids Composed of Quantum Dots and Cytochrome P450 as Photocatalysts (Angew. Chem. Int. Ed. 3/2006)
✍ Binil Itty Ipe; Christof M. Niemeyer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

Sunlight does chemistry in nanohybrids composed of CdS quantum dots (QDs) and enzyme P450~BSΞ²~. The hybrids, which are self‐assembled through electrostatic interactions between the negatively charged QDs and the positively charged His~6~‐marked P450, produce hydroxyl and superoxide radicals upon irr

Spectroscopic properties of p/p and o/o
Spectroscopic properties of p/p and o/o type Β­iron(III)-metal-free porphyrin dimers and their catalysis Β­as Cytochrome P450 model
✍ Qi-Zhi Ren; Jin-Wang Huang; Zhi-Ang Zhu; Liang-Nian Ji; Yun-Ti Chen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

Two series of p/p and o/o type iron(III)-metal-free porphyrin dimers were synthesized and characterized. The dimers consist of a ferric porphyrin and a free-base porphyrin, covalently linked with an alkoxy chain - O ( CH ~2~)~n~ O -(n = 2–10) at the para and ortho position of two phenyl rings. The f

Cytochrome P450 pharmacogenetics as a pr
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis
✍ Kazuki Takada; Million Arefayene; Zeruesenay Desta; Cheryl H. Yarboro; Dimitrios πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 133 KB

## Abstract ## Objective Pulse cyclophosphamide is the treatment of choice for severe lupus nephritis. However, not all patients respond to this therapy, and gonadal toxicity is of particular concern. Cyclophosphamide is a prodrug that requires activation by cytochrome P450 (CYP) enzymes. We condu